Status:
UNKNOWN
Vasculogenic Mimicry in Urothelial Carcinoma
Lead Sponsor:
Assiut University
Conditions:
Urothelial Carcinoma
Eligibility:
All Genders
Brief Summary
In this study, the investigators aim at: 1. Evaluate the presence of vasculogenic mimicry in urothelial carcinomas by CD31-PAS double staining. 2. Correlate the presence of vasculogenic mimicry with ...
Detailed Description
Bladder cancer is the ninth most common cancer worldwide which seriously affects human health. In Egypt, it is the third common malignant tumor. Urothelial carcinoma (UC) is considered the most commo...
Eligibility Criteria
Inclusion
- \- Specimens of urothelial carcinoma.
Exclusion
- \- Any criteria that not fulfill the inclusion criteria such as resected urinary bladder tumors other than urothelial carcinoma.
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04295967
Start Date
May 1 2020
End Date
May 1 2022
Last Update
March 5 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.